Wellington Management Group LLP Cytokinetics Inc Transaction History

Wellington Management Group LLP

$531 Billion
Q4 2024

A detailed history of Wellington Management Group LLP transactions in Cytokinetics Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 7,888,697 shares of CYTK stock, worth $396 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

7,888,697

Previous 7,774,970 1.46%

Holding current value

$396 Million

Previous $411 Million 9.61%

% of portfolio

0.07%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$46.36 - $58.62 $5.27 Million - $6.67 Million	113,727 Added 1.46%	7,888,697 $371 Million
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $13.6 Million - $16 Million	265,440 Added 3.53%	7,774,970 $411 Million
Q2 2024 Aug 13, 2024	BUY	$47.86 - $75.05 $169 Million - $265 Million	3,528,070 Added 88.61%	7,509,530 $407 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $254 Million - $430 Million	3,981,460 New	3,981,460 $279 Million
Q4 2023 Feb 12, 2024	BUY	$26.88 - $83.49 $174 Million - $542 Million	6,488,500 New	6,488,500 $542 Million
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $8.38 Million - $10.4 Million	-284,443 Reduced 3.44%	7,986,356 $235 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $24.3 Million - $30.3 Million	744,182 Added 9.89%	8,270,799 $270 Million
Q1 2023 May 12, 2023	BUY	$33.36 - $45.71 $32.8 Million - $45 Million	983,893 Added 15.04%	7,526,617 $265 Million
Q4 2022 Feb 13, 2023	BUY	$35.77 - $51.11 $61 Million - $87.2 Million	1,706,244 Added 35.28%	6,542,724 $300 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $37.3 Million - $52.8 Million	967,848 Added 25.02%	4,836,480 $234 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $85.6 Million - $123 Million	2,524,139 Added 187.74%	3,868,632 $152 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $6.59 Million - $10.2 Million	221,421 Added 19.72%	1,344,493 $49.5 Million
Q4 2021 Feb 11, 2022	BUY	$34.35 - $46.38 $2.45 Million - $3.3 Million	71,216 Added 6.77%	1,123,072 $51.2 Million
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $2.92 Million - $5.63 Million	-157,466 Reduced 13.02%	1,051,856 $37.6 Million
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $4.22 Million - $5.75 Million	213,045 Added 21.38%	1,209,322 $23.9 Million
Q1 2021 May 17, 2021	SELL	$18.57 - $25.68 $3.35 Million - $4.64 Million	-180,518 Reduced 15.34%	996,277 $23.2 Million
Q4 2020 Feb 12, 2021	SELL	$15.26 - $28.61 $26.9 Million - $50.5 Million	-1,763,744 Reduced 59.98%	1,176,795 $24.5 Million
Q3 2020 Nov 16, 2020	SELL	$20.58 - $28.96 $1.46 Million - $2.06 Million	-71,081 Reduced 2.36%	2,940,539 $63.7 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $33.6 Million - $74.2 Million	3,011,620 New	3,011,620 $71 Million

Others Institutions Holding CYTK

# of Institutions

396

Shares Held

122M

Call Options Held

3.46M

Put Options Held

1.86M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.73B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Cytokinetics Inc Transaction History